WallStreetZenWallStreetZen

AnalystsSoumit Roy
Soumit Roy's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Bottom 4%
#4409 out of 4563 analysts
Average Return
-31.11%
Win Rate
12%2 out of 17
Risk vs Reward
Poor
Good

Soumit Roy's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Cullinan Therapeutics IncCGEM
+115.64%$8.76$18.89
2023-10-05 -
2024-04-24
Strong Buy
Cullinan Therapeutics IncCGEM
+5.65%$17.88$18.89
2024-04-16 -
2024-04-24
Strong Buy

Soumit Roy Analyst Color

Get additional color on Soumit Roy's coverage of popular stocks

Soumit Roy's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Cullinan Therapeutics IncCGEM
2Strong Buy$26.00+37.64%Maintains
9 days ago
Janux Therapeutics IncJANX
1Strong Buy$70.00+45.20%Initiates Coverage On
10 days ago
Monopar TherapeuticsMNPR
2Strong Buy$2.00+204.41%Upgrades
15 days ago
In8bio IncINAB
1Strong Buy$5.00+371.70%Initiates Coverage On
a month ago
Acrivon Therapeutics IncACRV
1Strong Buy$26.00+173.68%Initiates Coverage On
8 months ago
Oncolytics Biotech IncONCY
1Strong Buy$9.00+749.06%Initiates Coverage On
a year ago
Coeptis Therapeutics Holdings IncCOEP
1Strong Buy$4.00N/AInitiates Coverage On
a year ago
Inhibikase Therapeutics IncIKT
2HoldN/AN/ADowngrades
a year ago
Hcw Biologics IncHCWB
1Strong Buy$8.00N/AInitiates Coverage On
a year ago
Aveo Pharmaceuticals IncAVEO
1Hold$15.00N/ADowngrades
a year ago
Rain Oncology IncRAIN
1Strong Buy$17.00N/AInitiates Coverage On
2 years ago
Ars Pharmaceuticals IncSPRY
2HoldN/AN/ADowngrades
2 years ago
Adicet Bio IncACET
1Strong Buy$33.00N/AInitiates Coverage On
3 years ago
Tracon Pharmaceuticals IncTCON
1Strong Buy$340.00N/AInitiates Coverage On
3 years ago
Celyad Oncology SaCYADY
1HoldN/AN/ADowngrades
3 years ago
Cassava Sciences IncSAVA
1Strong Buy$110.00N/AInitiates Coverage On
3 years ago
Precision Biosciences IncDTIL
1Strong Buy$810.00N/AInitiates Coverage On
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.